Rush University
Dr. Helen Ross obtained her MD at UCLA and completed specialty training in Internal Medicine at UCLA/Cedars Sinai Medical Center. She completed fellowship training in Hematology and Medical Oncology at UCLA. After more than 15 years in Arizona, Dr. Ross is delighted to relocate to Chicago to join Rush University in May 2023 as thoracic medical oncologist and as director of research and clinical trials for Rush Cancer Center. She has a particular interest in targeted therapies and cancer immunotherapy trials, especially as part of multi-modality therapy.
Thursday, May 4, 2023
4:15 PM – 5:15 PM ET
Session 10: Updates from Recent Meetings
Friday, May 5, 2023
11:00 AM – 11:45 AM ET
Session 8: HER2 and the Emerging Roles of HER Family ADCs
Thursday, September 21, 2023
4:20 PM – 5:05 PM ET
Session 12: Updates from Recent Meetings
Friday, September 22, 2023
11:45 AM – 12:30 PM ET
Session 7: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
Wednesday, November 29, 2023
3:45 PM – 4:20 PM ET
Wednesday, November 29, 2023
4:20 PM – 4:30 PM ET
Session 12: Updates from Recent Meetings
Thursday, November 30, 2023
12:30 PM – 1:05 PM ET
Thursday, November 30, 2023
1:05 PM – 1:15 PM ET